Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial

BACKGROUND: The presence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients is associated with reduced clinical outcome. Bisphosphonate treatment was shown to eradicate DTC from BM in several studies. This controlled randomized open-label multi-center study aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Banys, Malgorzata, Solomayer, Erich-Franz, Gebauer, Gerhard, Janni, Wolfgang, Krawczyk, Natalia, Lueck, Hans-Joachim, Becker, Sven, Huober, Jens, Kraemer, Bernhard, Wackwitz, Birgit, Hirnle, Peter, Wallwiener, Diethelm, Fehm, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015285/
https://www.ncbi.nlm.nih.gov/pubmed/24128322
http://dx.doi.org/10.1186/1471-2407-13-480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015285/
https://www.ncbi.nlm.nih.gov/pubmed/24128322
http://dx.doi.org/10.1186/1471-2407-13-480

Ejemplares similares